EMA QA Document for the Implementation of the Variations Guidelines
Recommendation

21/22 October 2026
Copenhagen, Denmark
The European Medicines Agency (EMA) has published a document with practical questions and answers to support the implementation of the variations guidelines in the centralised procedure. The Q&A Document provides practical considerations concerning the implementation of the various categories of variations, on the operation of the respective procedures and on the documentation to be submitted pursuant to those procedures (the 'variations guidelines')
The questions are organised into the following themes:
- general consideration
- new classification category C.1.11
- new classification category C.1.13
- impact on post-authorisation measure (PAM) submissions
- revised classification category C.I.8
- new classification category A.8
Source: EMA/427505/2013 Rev.1
Related GMP News
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan


